Category:

Journal and authors apologize “unreservedly” for distress caused to deceased child’s family by case report

aaicNeuroskeptic featured an interesting situation over the weekend, involving a case report published in an anesthesiology journal.

The case report in Anaesthesia and Intensive Care — about a six-year-old boy with a rare neurological condition who died following administration of anesthesia — caused the boy’s parents great distress when it appeared in November.

Misconduct at Oxford prompts retraction of insulin paper

cellmetabcoverCell Metabolism has retracted a 2006 article by a group of researchers at Oxford in England after an investigation concluded that the first author had committed misconduct.

The paper, “Nicotinamide nucleotide transhydrogenase: A key role in insulin secretion,” came from the lab of Frances Ashcroft, a world-renowned expert on ion channels. (We’ve written about Ashcroft’s lab before.)

According to the abstract: Continue reading Misconduct at Oxford prompts retraction of insulin paper

Former Hopkins and Pitt cancer researcher notches sixth retraction

GetzenbergRobert Getzenberg, a former researcher at Hopkins and Pitt, has retracted a sixth paper, this one in Cancer Research.

Here’s the notice for “Mechanistic Analysis of the Role of BLCA-4 in Bladder Cancer Pathobiology:” Continue reading Former Hopkins and Pitt cancer researcher notches sixth retraction

Should all correction notices be open access?

OrganometallicsChemistry blogger See Arr Oh was a bit irritated one day last week.

He’d found a correction in Organometallics, an American Chemical Society (ACS) journal, and the ACS wanted $35 to read it: Continue reading Should all correction notices be open access?

Bone-headed move? Authors of cancer-skeleton paper copy from paper in same journal

ImageClimacteric is retracting a 2013 article by a group of researchers in Seoul who used data from a paper by another duo of Korean scientists also published in, you guessed it, Climacteric.

The paper, “Different bone mineral density in cervical and endometrial cancer,” came from a group of  Soonchunhyang University and was published online late last year. It purported to look at the association between gynecologic cancers and bone mineral density:  Continue reading Bone-headed move? Authors of cancer-skeleton paper copy from paper in same journal

Citation manipulation: Journal retracts paper because author boosted references to a journal he edits

jpdcA group of researchers have lost a paper in a computer science journal because they were apparently using its references to help the impact factor of a different journal that one of them edits.

Here’s the notice for “Impacts of sensor node distributions on coverage in sensor networks,” a paper first published in 2011 and cited four times, according to Thomson Scientific’s Web of Knowledge: Continue reading Citation manipulation: Journal retracts paper because author boosted references to a journal he edits

DMCA notice forces removal of post critical of author who threatened to sue Retraction Watch

A blog post at another site that picked up on our coverage of Benjamin Jacob Hayempour, the researcher who has two retractions and has threatened to sue us, has been removed following a Digital Millenium Copyright Act (DMCA) takedown notice.

As Andrew Oh-Willkie, the blogger, writes in an account of the incident: Continue reading DMCA notice forces removal of post critical of author who threatened to sue Retraction Watch

Weekend reads: One researcher resents “cyberbullying” while another wishes peer reviewers would spank him

booksAnother busy week at Retraction Watch. Here’s what was going on around the web in scientific publishing and related issues:

“Copyright violation” fells tapeworm paper

jparadisWe have a report about a case report of a “rare presentation” that doesn’t seem to be as rare as the authors would like is to think it is.

Here’s what we’re talking about:

Continue reading “Copyright violation” fells tapeworm paper

Biotech company retracts Parkinson’s treatment study after “possible deviation from protocol”

LCTLiving Cell Technologies (LCT), a biotech company headquartered in Australia, has retracted a 2011 paper purporting to show that their product reversed Parkinson’s symptoms in rats after “being unable to reconfirm their reported results and a possible deviation from the protocol.”

LCT is developing NTCELL, which, according to their site: Continue reading Biotech company retracts Parkinson’s treatment study after “possible deviation from protocol”